According to cross-referenced reports from multiple media outlets, the leaked documents indicate that before the opening of the WHA, China’s diplomatic system prepared arguments and draft joint letters opposing Taiwan’s participation, and mobilized allies to sign them. This operational model is described as a complete "chain": China would issue the demand to block Taiwan, followed by allies signing and submitting the joint letters, ultimately achieving the goal of excluding Taiwan from the WHA. Reports point out that this process was accompanied by China providing substantial donations to the relevant allies, sparking strong public skepticism regarding "dollar diplomacy" and "political manipulation."

Currently, information regarding this incident is primarily concentrated on the leaked documents disclosed by the media and comments from political figures. DPP Legislator Chen Kuan-ting publicly stated that if the contents of the diplomatic files are true, this is not only a suppression of Taiwan’s international participation but also a serious "international scandal" that politicizes global public health issues and severely hinders the fairness of international medical cooperation. However, as of now, Chinese officials have not responded to the authenticity or content of these documents, and the details of the diplomatic operations and the flow of funds remain subject to further international verification.

This incident has profound implications for the global public health sector. As an important part of the international medical system, if Taiwan is excluded from the WHA due to political factors, it will create gaps in regional epidemic information exchange, infectious disease monitoring, and the coordination of public health policies. Particularly in regions like South America, which have faced diverse public health challenges in recent years, if international medical cooperation mechanisms are obstructed by the political maneuvering of major powers, it could weaken global resilience in responding to public health emergencies and affect international exchanges and scientific research cooperation in the medical industry.

There are divergent views in academia and political circles regarding such incidents. Perspectives supporting Taiwan’s participation argue that public health knows no borders and that any political blockade violates the World Health Organization’s (WHO) mission to ensure health for all. However, some international relations observers caution that in the current complex geopolitical environment, the sources and political motivations of such diplomatic documents must be carefully evaluated to avoid over-interpreting the impact of a single event on the global health governance structure. They suggest that the boundaries between decision-making mechanisms within international organizations and diplomatic maneuvering should be clarified to prevent information from being used in a one-sided manner.

Future observation will focus on the international community’s reaction to China’s diplomatic tactics and whether the Taiwanese government will take further international lobbying or legal action against such diplomatic blockades. Additionally, whether subsequent WHA meeting decisions will be affected by this incident, leading to adjustments in participation mechanisms for non-member states, is also a key point of concern for global public health observers. As global demands for information transparency and the impartiality of international organizations continue to rise, this type of controversy involving the politicization of public health is expected to continue fermenting in international forums.

Beyond public health governance, discussions on information transparency and technical regulation are also heating up globally. For example, tech giant Meta recently pushed a firmware update for its AI smart glasses aimed at blocking a bypass vulnerability that allowed users to "secretly record" by covering the privacy indicator light. Such technical privacy protections and the issue of diplomatic transparency in international politics together form the complex landscape of current global governance. When public health cooperation faces the challenge of political blockades while simultaneously needing to address the privacy risks posed by emerging technologies, the international community’s need for fair, transparent, and resilient collaborative mechanisms becomes increasingly urgent.

Furthermore, despite the challenging international political environment, cross-border cooperation in medical research continues to advance. For instance, the anti-cancer drug Pidnarulex (CX-5461) from Senhwa Biosciences, supported by the U.S. National Cancer Institute (NCI) program, has completed its first clinical enrollment in combination with a major international immune checkpoint inhibitor. Such scientific achievements demonstrate that even under the shadow of political maneuvering, the global medical industry remains committed to seeking breakthroughs in treating intractable diseases through multinational clinical validation. These developments contrast with the political controversy of the WHA, highlighting the ongoing tug-of-war between scientific cooperation and political blockades.